Perineural Prolotherapy in Chronic Knee Osteoarthritis Pain.
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- National and Kapodistrian University of Athens
- Trial code
- NCT07245121
- Record updated
- 2 December 2025
- Original description
The aim of this study is to test whether the addition of dextrose to perineural injections is superior to local anesthetic alone, as some initial data have indicated. To enhance the potential therapeutic effect, we will proceed to a 4-point injection technique, targeting 4 genicular nerves (superomedial, superolateral, inferomedial, recurrent peroneal genicular nerve) in a randomized controlled trial with two arms.Read full original descriptionShow less
Perineural Prolotherapy in Chronic Knee Osteoarthritis Pain: A Randomized Controlled Trial.
The aim of this study is to test whether the addition of dextrose to perineural injections is superior to local anesthetic alone, as some initial data have indicated. To enhance the potential therapeutic effect, we will proceed to a 4-point injection technique, targeting 4 genicular nerves (superomedial, superolateral, inferomedial, recurrent peroneal genicular nerve) in a randomized controlled trial with two arms.
Inclusion: Patients of both sexes; Age >38 years; Body Mass Index (BMI) up to 42 kg/m2; Diagnosis of knee osteoarthritis, according to the clinical criteria of the American College of Rheumatology. Osteoarthritis if the following combinations are present:; A, B, C, D or A, B, E or A, D, E:; Knee pain most days of the previous month B) Cracking during active joint movement C) Morning stiffness lasting at least 30 minutes D) Age at least 38 years E) Bone swelling of the affected knee on physical examination; Chronic knee pain on the Numerical Rating Scale (NRS) > 5 for at least 3 months prior to the study; Grade 2 or 3 osteoarthritis, according to the Kellgern-Lawrence classification; Pain, creaking, and stiffness in the knee joint that persists for at least three months prior to the study.
Exclusion: History of previous total knee arthroplasty or other knee surgery; Any infection of the skin of the knee joint, such as cellulitis, or periarticular or intraarticular infection during the last 3 months; Poorly controlled diabetes mellitus or connective tissue disease affecting the knee joint; History of knee injury or fracture within the last 3 months; History of acute lumbosacral radiculopathy or peripheral neuropathy, neurological, psychiatric disease; History of limb malignancy; History of bleeding disorder; Allergy to local anesthetics, needle phobia; Difficulty communicating (severe hearing loss, dementia, language problems); History of periarticular or intraarticular injection of corticosteroids, local anesthetic, hyaluronic acid, platelet-rich plasma, radiofrequency, prolotherapy within the last trimester; Pain limited in the posterior aspect of the knee; Pregnancy; Non-guaranteed transportation to hospital for treatments and re-evaluations.